BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatosis
1
Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
10/21/2024 7:03:25 AM | Browse: 48 | Download: 139
2
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
7/4/2022 12:30:52 PM | Browse: 414 | Download: 867
3
Metabolic aspects of hepatitis C virus
6/10/2022 5:40:20 AM | Browse: 467 | Download: 948
4
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 518 | Download: 856
5
Glycogen hepatopathy in type-1 diabetes mellitus: A case report
2/22/2022 9:25:38 AM | Browse: 429 | Download: 839
6
Nonalcoholic fatty liver disease shows significant sex dimorphism
2/11/2022 5:55:19 AM | Browse: 433 | Download: 1156
7
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
1/21/2022 8:16:14 AM | Browse: 553 | Download: 1156
8
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
10/20/2021 7:18:39 AM | Browse: 412 | Download: 696
9
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 627 | Download: 938
10
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
8/4/2021 7:56:20 AM | Browse: 443 | Download: 1214
11
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
7/12/2021 12:42:13 AM | Browse: 604 | Download: 1275
12
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 521 | Download: 1360
13
Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
6/18/2021 5:06:16 AM | Browse: 535 | Download: 1283
14
Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients
5/8/2021 7:57:00 AM | Browse: 587 | Download: 1250
15
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
3/18/2021 10:54:40 AM | Browse: 720 | Download: 1095
16
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
2/5/2021 10:20:18 AM | Browse: 606 | Download: 1452
17
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
11/24/2020 12:41:21 PM | Browse: 671 | Download: 1588
18
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
11/6/2020 7:36:12 AM | Browse: 700 | Download: 1752
19
Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis
9/4/2020 7:25:49 AM | Browse: 714 | Download: 1914
20
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
8/7/2019 7:09:17 AM | Browse: 892 | Download: 1349
21
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 867 | Download: 1085
22
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 1079 | Download: 1918
23
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1177 | Download: 1646
24
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 1153 | Download: 1636
25
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
1/21/2019 5:38:30 AM | Browse: 1144 | Download: 1464
26
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 1307 | Download: 1733
27
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 998 | Download: 1626
28
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
9/25/2018 3:44:36 AM | Browse: 1076 | Download: 1642
29
Feasibility of using marginal liver grafts in living donor liver transplantation
6/15/2018 9:13:16 AM | Browse: 1204 | Download: 1408
30
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 1286 | Download: 1289
31
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1348 | Download: 2133
32
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
1/19/2018 9:46:49 AM | Browse: 1231 | Download: 1603
33
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 1092 | Download: 1796
34
Non-alcoholic fatty liver disease: An expanded review
6/6/2017 12:54:56 AM | Browse: 1534 | Download: 1526
35
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
5/20/2017 12:26:24 PM | Browse: 1268 | Download: 1523
36
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
5/16/2017 6:56:36 AM | Browse: 1426 | Download: 2308
37
Non-alcoholic fatty liver disease and cardiovascular risk
5/16/2017 6:56:36 AM | Browse: 1425 | Download: 1434
38
Changes in human hepatic metabolism in steatosis and cirrhosis
4/20/2017 3:58:56 PM | Browse: 1693 | Download: 2441
39
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 1565 | Download: 2059
40
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
12/27/2016 8:31:00 AM | Browse: 1525 | Download: 2450
41
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 1367 | Download: 1830
42
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
11/6/2016 3:43:00 PM | Browse: 1435 | Download: 1516
43
Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease
9/22/2016 9:52:00 AM | Browse: 1409 | Download: 2534
44
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
3/29/2016 3:29:00 PM | Browse: 1384 | Download: 2620
45
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
1/26/2016 6:22:00 PM | Browse: 1497 | Download: 2408
46
Mechanisms of intrahepatic triglyceride accumulation
1/20/2016 5:04:00 PM | Browse: 1498 | Download: 1646
47
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis
12/4/2015 3:24:00 PM | Browse: 1283 | Download: 1791
48
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
12/2/2015 12:20:00 PM | Browse: 1445 | Download: 1252
49
Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan®)
11/11/2015 1:33:00 PM | Browse: 1585 | Download: 2083
50
Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
10/30/2015 11:57:00 AM | Browse: 1186 | Download: 2431
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345